Editors in Chief
- Paolo Casali, Istituto Nazionale Tumori, Milan
- Angelo Paolo Dei Tos, Treviso General Hospital
Managing Editor
- Joanne Fleming, Treviso General Hospital
Articles
-
Research
Clinical Sarcoma Research 2012, 2:8 (8 February 2012)Histone Deacetylase Inhibitors Enhance Expression of NKG2D Ligands in Ewing Sarcoma and Sensitize for Natural Killer Cell-Mediated Cytolysis
-
Short Report
Clinical Sarcoma Research 2012, 2:7 (8 February 2012)The clinical use of biomarkers as prognostic factors in Ewing sarcoma
-
Review
Clinical Sarcoma Research 2012, 2:6 (1 February 2012)Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/ primitive neuroectodermal tumours
-
Short Report
Clinical Sarcoma Research 2012, 2:5 (27 January 2012)Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment.
-
Research
Clinical Sarcoma Research 2012, 2:4 (27 January 2012)Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans
-
Case Report
Clinical Sarcoma Research 2012, 2:3 (25 January 2012)Paratesticular desmoplastic small round cell tumor: an unusual tumor with an unusual fusion, cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH
-
Research
Clinical Sarcoma Research 2012, 2:2 (24 January 2012)Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma
-
Research
Clinical Sarcoma Research 2012, 2:1 (9 January 2012)An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma.
- View more articles
Aims & scope
Clinical Sarcoma Research publishes original articles and review articles on diagnosis and treatment of sarcomas. It hosts new insights in sarcoma research, which may be of immediate or future interest for diagnosis and treatment. These include negative results, especially from studies on new agents. In fact, it is vital for the medical community to learn whether new agents have proven effective or ineffective, all the more in subtypes of sarcomas, thus avoiding any publication bias. The journal also aims to offer a forum for active discussion on topics of major interest for the sarcoma community. This may affect both research results and methodological topics.
Email updates
Receive periodic news and updates relating to this journal.